Sort:
Relevance
Filter:
All

75 result(s) found

Piper downgrades Achilles to neutral, cites latest data https://seekingalpha.com/news/4087599-piper-downgrades-achilles-to-neutral-cites-latest-data?source=feed_sector_healthcare Apr 05, 2024 - Piper Sandler has downgraded Achilles (ACHL) to neutral in the wake of Phase 1/2 data from its CHIRON and THETIS studies for its precision T cell therapy. Read more here.
Bristol Myers, 2seventy bio's Abecma approved for earlier line multiple myeloma https://seekingalpha.com/news/4087581-bristol-myers-2seventy-bio-receive-fda-approval-for-abecma-to-treat-multiple-myeloma?source=feed_sector_healthcare Apr 05, 2024 - The CAR T therapy Abecma has been approved for adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy. Read more here.
Top Analyst Reports for T-Mobile US, Abbott Laboratories & Palo Alto Networks https://www.zacks.com/commentary/2251046/top-analyst-reports-for-t-mobile-us-abbott-laboratories-palo-alto-networks?cid=CS-ZC-FT-research_daily-2251046 Apr 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).
The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services https://www.zacks.com/stock/news/2251993/the-zacks-analyst-blog-highlights-t-mobile-us-abbott-laboratories-palo-alto-networks-enterprise-products-partners-and-the-pnc-financial-services?cid=CS-ZC-FT-press_releases-2251993 Apr 08, 2024 - T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services are part of the Zacks top Analyst Blog.
T. Rowe (TROW) Upgraded to Strong Buy: What Does It Mean for the Stock? https://www.zacks.com/stock/news/2254046/t-rowe-trow-upgraded-to-strong-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2254046 Apr 11, 2024 - T. Rowe (TROW) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
M&T Bank Corporation (MTB) Q1 2024 Earnings Call Transcript https://seekingalpha.com/article/4683831-m-and-t-bank-corporation-mtb-q1-2024-earnings-call-transcript?source=feed_sector_transcripts Apr 15, 2024 - M&T Bank Corporation (NYSE:NYSE:MTB) Q1 2024 Earnings Call Transcript April 15, 2024 8:00 AM ETCompany ParticipantsBrian Klock - Investor RelationsDaryl...
M&T Bank (MTB) Reports Q1 Earnings: What Key Metrics Have to Say https://www.zacks.com/stock/news/2255223/m-t-bank-mtb-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2255223 Apr 15, 2024 - The headline numbers for M&T Bank (MTB) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ford recalls nearly 43,000 SUVs due to gas leaks that can cause fires, but remedy won’t fix leaks https://www.boston.com/cars/national-news/2024/04/10/ford-recalls-nearly-43000-suvs-due-to-gas-leaks-that-can-cause-fires-but-remedy-wont-fix-leaks/ Apr 10, 2024 -

Ford is recalling nearly 43,000 small SUVs because gasoline can leak from the fuel injectors onto hot engine surfaces, increasing the risk of fires

The post Ford recalls nearly 43,000 SUVs due to gas leaks that can cause fires, but remedy won’t fix leaks appeared first on Boston.com.

3 Top Tech Stocks to Buy in April https://www.fool.com/investing/2024/04/19/3-top-tech-stocks-to-buy-in-april/?source=iedfolrf0000001 Apr 19, 2024 - AT&T, TSMC, and Palo Alto Networks could head higher throughout the rest of the year.
T. Rowe Price (TROW) Reports Next Week: Wall Street Expects Earnings Growth https://www.zacks.com/stock/news/2258521/t-rowe-price-trow-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2258521 Apr 19, 2024 - T. Rowe (TROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Pages: 12345678

<Page 2>